Value of the Multibiomarker Disease Activity Score to Predict Remission in RA: What Does the Evidence Show?-Reference-Cited by-同舟云学术

Value of the Multibiomarker Disease Activity Score to Predict Remission in RA: What Does the Evidence Show?

Published:2019-05 Issue:5 Volume:46 Page:443-446
ISSN:0315-162X
Container-title:The Journal of Rheumatology
language:en
Short-container-title:J Rheumatol

Author:

FLEISCHMANN ROY^ORCID

Publisher

The Journal of Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference15 articles.

1. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

2. Two-year results from the Ample Trial: Low disease activity and association between remission and changes in physical function and radiographic outcomes with subcutaneous abatacept or adalimumab;Fleischmann;Arthritis Rheum,2013

3. Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis

4. Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity

5. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galectin-3, Matrix Metalloproteinase-3 and TLR-2 Receptor as Novel Biomarkers in the Diagnosis of Rheumatoid Arthritis;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-08-07

2. Novel approaches to develop biomarkers predicting treatment responses to TNF-blockers;Expert Review of Clinical Immunology;2021-04-03

3. What further data are needed to value the Multi‐Biomarker Disease Activity score for measuring rheumatoid arthritis disease activity: comment on the article by Johnson et al;Arthritis Care & Research;2020-07-23

4. Multiple biomarker approach for the diagnosis and therapy of rheumatoid arthritis;Critical Reviews in Clinical Laboratory Sciences;2020-06-19

5. Response to: “Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation” by Masi and Fleischmann;Arthritis Research & Therapy;2020-03-20